November 19, 2008 - IntraOp Medical Corp. announced its second German order for the Mobetron, which delivers intraoperative electron-beam radiation therapy (IOERT) to cancer patients.
The University Hospital Giessen and Marburg GmbH (Marburg), located in Marburg, Germany will be the second Mobetron installation in Germany. The first is the Strahleninstitut in Cologne.
The Mobetron reportedly enables surgeons and radiation oncologists to target the exact area that requires radiation and to deliver high doses of radiation directly to the affected tissue during the cancer surgery. The mobile, self-shielded linear accelerator can move between operating rooms with ease, avoiding the high cost of building shielded vaults to accommodate traditional linear accelerators. Key patient benefits of IOERT are said to include: lower recurrence rates, increased survival rates, shorter treatment cycles and fewer side effects.
Marburg is a leading hospital for cancer care in Germany, maintaining more than 1,000 beds and conducting nearly 15,000 operations in eighteen operating theatres each year.
Professor Engenhart-Cabilic of the department for Radio-Oncology at Marburg, commented, “We are very excited to bring the Mobetron and IOERT to Marburg. By providing this form of radiation treatment to our cancer patients, we are able to offer them the best in cancer care.”
For more information: www.intraopmedical.com


Related Content

News | Radiology Business

April 10, 2026 — The radiation therapy team at The Ohio State University Wexner Medical Center, The James Cancer ...

Time April 10, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | FDA

March 20, 2026 — Siemens Healthineers recently announced its Varian TrueBeam radiotherapy systems, which include ...

Time March 24, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Subscribe Now